目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Nutrigenomics Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Nutrigenomics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape

Chapter 4. Nutrigenomics Market: Application Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Nutrigenomics Market: Application Movement Analysis, 2023 & 2030 (USD Million)
4.3. Obesity
4.3.1. Obesity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Cardiovascular Diseases
4.4.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Cancer Research
4.5.1. Cancer Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Others
4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Nutrigenomics Market: Product Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Nutrigenomics Market: Product Movement Analysis, 2023 & 2030 (USD Million)
5.3. Reagents & Kits
5.3.1. Reagents &Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Services
5.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Nutrigenomics Market: Technique Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Nutrigenomics Market: Technique Movement Analysis, 2023 & 2030 (USD Million)
6.3. Saliva
6.3.1. Saliva Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Buccal Swab
6.4.1. Buccal Swab Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Blood
6.5.1. Blood Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Nutrigenomics Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Nutrigenomics Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
7.3. Hospitals & Clinics
7.3.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Others
7.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Nutrigenomics Market: Regional Estimates & Trend Analysis
8.1. Nutrigenomics Market Share, By Region, 2023 & 2030 (USD Million)
8.2. North America
8.2.1. North America Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Mexico Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. UK Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. France Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Italy Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Spain Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Denmark Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Sweden Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Norway Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.2. China
8.4.2.1. China Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.3. Japan
8.4.3.1. Japan Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. India Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.5. South Korea
8.4.5.1. South Korea Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.6. Australia
8.4.6.1. Australia Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Thailand Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.3. Argentina
8.5.3.1. Argentina Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Saudi Arabia Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. UAE Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Kuwait Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Nutrigenomix
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/Strategic Initiatives
9.4.2. The Gene Box
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/Strategic Initiatives
9.4.3. Metagenics
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/Strategic Initiatives
9.4.4. Xcode Life
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/Strategic Initiatives
9.4.5. GX Sciences, LLC (Fagron)
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/Strategic Initiatives
9.4.6. Cura Integrative Medicine
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/Strategic Initiatives
9.4.7. dnalife
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/Strategic Initiatives
9.4.8. Genova Diagnostics (GDX)
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/Strategic Initiatives
9.4.9. HOLISTIC HEALTH INTERNATIONAL, LLC
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/Strategic Initiatives